SYT4 and neoplasm: Furthermore, we identified borussertib, a covalent allosteric inhibitor of SYT4, which selectively suppresses SYT4-driven tumor growth in GC cells and xenograft models by inhibiting the Wnt/β-catenin pathway 11.